<< Read Full Article
<< Read Full Article
Next up in the 2008 biotech sector prep: A calendar of expected clinical trials.
The calendar I've put together below captures most of the major phase III studies being conducted by biotech firms for which top-line results are expected in calendar year 2008.
The list includes a smattering of important mid-stage, or phase II, studies. I purposely omitted studies conducted by large pharmaceutical firms. Those are important too, but they tend not to move stocks as much. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,456.46 | 1,110.39 | 2,194.96 | 33.67 |
Oil *
78.45
|
|
UP
3.78
|
UP
1.15
|
UP
9.93
|
UP
0.44
|
10 Yr
3.37%
SPDR Gold
118.96
|
|
+0.04%
|
+0.10%
|
+0.45%
|
+1.32%
|
Data delayed 20 minutes |
Connect with TheStreet